🎙️ “This isn’t red tape. It’s obstruction.”<br />— Duane Boise, CEO of MMJ International Holdings, on Cannabis Coast to Coast News (7/14/25)<br /><br />🚨 In his explosive national interview, Duane Boise exposes the DEA’s ongoing sabotage of FDA-authorized medical cannabis research. Despite full regulatory compliance and millions invested in a pharmaceutical-grade facility, MMJ BioPharma has been blocked from launching its Huntington’s disease and MS trials—because the DEA refuses to issue a bulk manufacturing license.<br /><br />🔥 Boise’s Highlights:<br />✅ “We followed every rule—but DEA weaponized the system against us.”<br />✅ “The DEA’s administrative process isn’t just broken—it’s unconstitutional.”<br />✅ “We’re filing a federal lawsuit to hold corrupt officials accountable and defend patient access.”<br /><br />🧠 MMJ’s mission: Advance pharmaceutical-grade cannabinoid drugs—not dispensary products—via FDA pathways, for diseases with no cure.
